Table 1 Baseline characteristics of participants and lab indicators before treatment by group

 Female^*

195 (60.0)

53 (52.4)

23 (69.7)

15 (88.2)

51 (76.1)

52 (50.0)

 Male

130 (40.0)

50 (47.6)

10 (30.3)

2 (11.8)

16 (23.9)

52 (50.0)

Age^*

46.6 ± 16.7

51.0 ± 17.3

35.3 ± 11.1

39.8 ± 8.5

46.5 ± 17.5

47.2 ± 16.1

BMI

29.3 ± 7.0

29.0 ± 6.3

28.2 ± 7.0

28.5 ± 4.2

31.0 ± 9.3

29.0 ± 6.1

Hb in g/dL

N/A

9.7 ± 1.5

10.6 ± 2.0

11.1 ± 1.6

11.3 ± 2.1

13.9 ± 1.4

RBC × 10¹²/L

N/A

4.3 ± 0.60

3.9 ± 0.89

4.8 ± 1.1

4.0 ± 0.81

4.8 ± 0.51

MCV fL

N/A

75.6 ± 9.1

84.5 ± 12.4

66.4 ± 7.7

89.4 ± 9.5

88.9 ± 5.1

RDW %

N/A

16.5 ± 3.3

17.5 ± 3.8

15.1 ± 2.8

15.0 ± 4.2

13.3 ± 1.3

MCH

N/A

25.5 ± 10.5

27.3 ± 4.6

20.6 ± 2.9

28.9 ± 3.6

29.0 ± 1.9

Glu F in mmol/L^a

N/A

5.2 ± 0.53

5.21 ± 0.5

5.07 ± 0.65

5.06 ± 0.68

5.2 ± 0.57

Creatinine in micromol/L^b

N/A

73.2 ± 25.0

67.49 ± 31.44

60.54 ± 10.13

68.32 ± 17.98

70.12 ± 12.05

Bilirubin in micromol/L^c

N/A

9.4 ± 6.85

23.65 ± 21.41

14.46 ± 5.24

10.94 ± 7.49

10.33 ± 5.03

Ferritin in mcg/L

N/A

22.3 ± 52.1

76.46 ± 89.51

69.86 ± 85.61

89.88 ± 153.63

89.21 ± 73.79

B12 in pmol/L

N/A

N/A

N/A

N/A

108.72 ± 23.54

N/A